- Home
- MBI vs ESPR Comparison
MBI vs ESPR Comparison
Compare MBI & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- ESPR
- Stock Information
- Founded
- MBI 1973
- ESPR 2008
- Country
- MBI United States
- ESPR United States
- Employees
- MBI N/A
- ESPR N/A
- Industry
- MBI Property-Casualty Insurers
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- MBI Finance
- ESPR Health Care
- Exchange
- MBI Nasdaq
- ESPR Nasdaq
- Market Cap
- MBI 278.8M
- ESPR 305.0M
- IPO Year
- MBI 1987
- ESPR 2013
- Fundamental
- Price
- MBI $5.46
- ESPR $1.69
- Analyst Decision
- MBI Buy
- ESPR Buy
- Analyst Count
- MBI 2
- ESPR 7
- Target Price
- MBI $6.75
- ESPR $6.36
- AVG Volume (30 Days)
- MBI 450.4K
- ESPR 4.2M
- Earning Date
- MBI 05-08-2025
- ESPR 03-04-2025
- Dividend Yield
- MBI N/A
- ESPR N/A
- EPS Growth
- MBI N/A
- ESPR N/A
- EPS
- MBI N/A
- ESPR N/A
- Revenue
- MBI $27,000,000.00
- ESPR $332,314,000.00
- Revenue This Year
- MBI N/A
- ESPR $5.51
- Revenue Next Year
- MBI N/A
- ESPR $1.42
- P/E Ratio
- MBI N/A
- ESPR N/A
- Revenue Growth
- MBI 285.71
- ESPR 185.66
- 52 Week Low
- MBI $3.22
- ESPR $1.47
- 52 Week High
- MBI $7.46
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- MBI 39.86
- ESPR 49.78
- Support Level
- MBI $4.93
- ESPR $1.47
- Resistance Level
- MBI $5.68
- ESPR $1.61
- Average True Range (ATR)
- MBI 0.29
- ESPR 0.12
- MACD
- MBI 0.03
- ESPR 0.02
- Stochastic Oscillator
- MBI 69.74
- ESPR 56.41
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.